Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Science Advances|February 9, 2024
Stromal-derived MAOB promotes prostate cancer growth and progressionTianjie Pu, Jing Wang, Jing Wei, et al.
Research Square|April 8, 2024
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancerChengfei Liu, Bo Chen, Pengfei Xu, et al.
Biomedicines|May 27, 2026
Characterizing Response to PARP Inhibitor Treatment Combinations in Advanced Prostate CancerBryan Correa Gonzalez, Akshaya Karthikeyan, Love A Moore, et al.
Cancer Research|May 19, 2006
Hypoxia increases androgen receptor activity in prostate cancer cellsSoo-Yeon Park, Yun-Jeong Kim, Allen C Gao, et al.
Cancers|October 16, 2025
Dynamic Reprogramming of Immune-Related Signaling During Progression to Enzalutamide Resistance in Prostate CancerPengfei Xu, Huan Qu, Joy C Yang, et al.
Oncogene|June 14, 2024
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancerBo Chen, Pengfei Xu, Joy C Yang, et al.
Cancer Research Communications|October 23, 2024
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer CellsZachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Molecular Cancer Therapeutics|January 28, 2022
Olaparib-Induced Senescence Is Bypassed through G2-M Checkpoint Override in Olaparib-Resistant Prostate CancerAlan P Lombard, Cameron M Armstrong, Leandro S D'Abronzo, et al.
Molecular Cancer Therapeutics|August 5, 2022
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide TreatmentShu Ning, Chengfei Liu, Wei Lou, et al.
International Journal of Molecular Sciences|July 15, 2026
Glutamate Ionotropic Kainate Receptors as Therapeutic Targets in Enzalutamide-Resistant and Neuroendocrine Prostate CancerHuan Qu, Pengfei Xu, Joy C Yang, et al.
Pageof 15